Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up

Efstratios M. Κolibianakis, Claire Bourgain, Carola Albano, +4

Fertility and Sterility

InfertilityFertilityUterine ReceptivityGynecologyOocyte Pick-up +11

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

Carola Albano, R. Felberbaum, Johan Smitz, +4

Human Reproduction

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

Carola Albano, Johan Smitz, Michel Camus, +3

Fertility and Sterility

Hormonal ContraceptiveUrologyControlled Ovarian HyperstimulationGynecologyUrogynecology +6

Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy

Efstratios M. Κolibianakis, Carola Albano, Jarl A. Kahn, +4

Fertility and Sterility

Early Follicular PhaseFertilityReduced ChanceReproductive HealthGynecology +11

Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists

Efstratios M. Κolibianakis, Carola Albano, Michel Camus, +3

Fertility and Sterility

Gonadotropin-releasing Hormone AntagonistsInfertilityHormonal ContraceptiveDevelopmental BiologyFertility +11

The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix

Carola Albano, Grigoris Grimbizis, Johan Smitz, +4

Fertility and Sterility

Luteal PhaseOvarian SuperovulationHormonal ContraceptiveFertilityNonsupplemented Cycles +11

Human Oocytes Reversibly Arrested in Prophase I by Phosphodiesterase Type 3 Inhibitor In Vitro1

Daniela Nogueira, Carola Albano, Tom Adriaenssens, +4

Biology of Reproduction

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction

Mirna Stela Ludwig, R. Felberbaum, Paul Devroey, +5

Archives of Gynecology and Obstetrics

Hormonal ContraceptiveUrologyFertilitySignificant ReductionReproductive Health +9

Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix

Asimina Tavaniotou, Carola Albano, Johan Smitz, +1

Human Reproduction

Endocrinology: Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles

F. Ubaldi, Carola Albano, M. Peukert, +5

Human Reproduction

Hormonal ContraceptiveFertilitySperm InjectionGynecologyFemale Reproductive Function +16